Neuralink’s 3rd human implant 2025 marks milestone, 20-30 more planned, Digital Health News November 3—Musk’s Las Vegas X stream confirms all three function well for paralysis reconnection.
Blindsight’s monkey trials elicit 66% visual responses, FDA breakthrough status accelerates human trials for blind via visual cortex stimulation, bypassing optic nerves.
PRIME Study expands to Canada UK Germany UAE, targeting quadriplegia from spinal injuries ALS, reconnecting patients to computers smartphones robots via thoughts.
Veiled vectors: First implant Noland Arbaugh reconnects post-thread retraction via software, second deeper threads reduce motion, third builds momentum for 2026 pivotal 20-40 patient trial.
Economic dialectics: $1T compute pacts OpenAI, Neuralink’s veiled veil transmutes paralysis’s specter into autonomy’s enduring idyll.
This trial’s subtle symphony unveils not implant’s cadence, but interface’s durable dance—veiled veils of 3rd patient from 20-30, where tech‘s artistry yields reinvention’s radius in neuroscience’s majestic march.
